 China Biologic Products Holdings, Inc. NASDAQ: CBPO China Biologic or the Company, a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release its second quarter 2020 financial results on Monday, August 17, 2020 after the market closes. 